1. Youth-Onset Type 2 Diabetes Mellitus: Lessons Learned From the TODAY Study 
Sumana Narasimhan, MD, Ruth S. Weinstock, MD, PhD 
Mayo Clinic Proceedings 
Volume 89, Issue 6, Pages (June 2014)
DOI: /j.mayocp
Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1
Design of the Treatment Options for Type 2 Diabetes in Adolescents and Youth study. ACE-I = angiotensin-converting enzyme inhibitor; BMI = body mass index; GAD-65 = glutamic acid decarboxylase; HbA1c = hemoglobin A1c; IA-2 = insulinoma-associated protein 2. SI conversion factors: To convert C-peptide to nmol/L, multiply by 0.331; to convert HbA1c to proportion of total hemoglobin, multiply by 0.01.
Adapted from Pediatr Diabetes,19 with permission. Data also from N Engl J Med.20
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
The Treatment Options for Type 2 Diabetes in Adolescents and Youth study: overall primary outcome results. Survival curves for freedom from glycemic failure are shown. Data are for up to 60 months of follow-up (accounting for 98.4% of cases of glycemic failure), although the rates and analysis are based on the complete data set.
From N Engl J Med,20 with permission.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions